LESLIE THOMAS: Open Payments
NPI 1164616421 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 36 payments from 11 companies in 2025. Trend: 2023 $568 · 2024 $859 · 2025 $757
Food & beverage: $648Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $231 |
| Alkermes, Inc. | 4 | $95 |
| Neurocrine BioSciences, Inc. | 3 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| ABBVIE INC. | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Lundbeck LLC | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $24 |
Products named: INGREZZA, ARISTADA, UZEDY, AUSTEDO XR, CAPLYTA, VRAYLAR, INVEGA SUSTENNA, REXULTI.
Industry payments across OH — which companies pay providers there.
